Publications

Sort by: Date | Author | Title

Brøsen, K., Andersen, S. E., Borregaard, J., Christensen, H. R., Christensen, P. M., Dalhoff, K. P., Damkier, P., Hallas, J., Heisterberg, J., Jessen, N., Jürgens, G., Kampmann, J. P. K., Laursen, B. E., Laursen, T., Nielsen, L. P., Poulsen, B. K., Poulsen, H. E., Andersen, L. V., Senderovitz, T. & Sonne, J. (2016). Clinical Pharmacology in Denmark in 2016 - 40 Years with the Danish Society of Clinical Pharmacology and 20 Years as a Medical Speciality. Basic and Clinical Pharmacology and Toxicology, 119(6), 523-532. https://doi.org/10.1111/bcpt.12681
Brüggemann, H. (2016). The emerging role of propionibacteria in human health and disease. In The Human Microbiota and Chronic Disease: Dysbiosis as a Cause of Human Pathology (pp. 199-214). John Wiley & Sons. https://doi.org/10.1002/9781118982907.ch12
Burt, S. A., Adolfse, S. J. M., Ahad, D. S. A., Tersteeg-Zijderveld, M. H. G., Jongerius-Gortemaker, B. G. M., Post, J. A., Brüggemann, H. & Santos, R. R. (2016). Cinnamaldehyde, Carvacrol and Organic Acids Affect Gene Expression of Selected Oxidative Stress and Inflammation Markers in IPEC-J2 Cells Exposed to Salmonella typhimurium. Phytotherapy Research, 30(12), 1988-2000. https://doi.org/10.1002/ptr.5705
Cabrera, S. M., Wang, X., Chen, Y.-G., Jia, S., Kaldunski, M. L., Greenbaum, C. J., Mandrup-Poulsen, T., Hessner, M. J., Type 1 Diabetes TrialNet Canakinumab Study Group & Rungby, J. (2016). Interleukin-1 antagonism moderates the inflammatory state associated with Type 1 diabetes during clinical trials conducted at disease onset. European Journal of Immunology, 46(4), 1030-1046. https://doi.org/10.1002/eji.201546005
Cao, H., Bertolino, A., Walter, H., Schneider, M., Schäfer, A., Taurisano, P., Blasi, G., Haddad, L., Grimm, O., Otto, K., Dixson, L., Erk, S., Mohnke, S., Heinz, A., Romanczuk-Seiferth, N., Mühleisen, T. W., Mattheisen, M., Witt, S. H., Cichon, S. ... Meyer-Lindenberg, A. (2016). Altered Functional Subnetwork During Emotional Face Processing: A Potential Intermediate Phenotype for Schizophrenia. JAMA Psychiatry, 73(6), 598-605. https://doi.org/10.1001/jamapsychiatry.2016.0161
Cehofski, L. J., Kruse, A., Bøgsted, M., Magnusdottir, S. O., Stensballe, A., Honoré, B. & Vorum, H. (2016). Retinal Proteome Changes Following Experimental Branch Retinal Vein Occlusion and Intervention with Ranibizumab. Experimental Eye Research, 152, 49-56. https://doi.org/10.1016/j.exer.2016.09.002
Cheng, L., Pisitkun, T., Knepper, M. A. & Hoffert, J. D. (2016). Peptide labeling using isobaric tagging reagents for quantitative phosphoproteomics. In Methods in Molecular Biology (pp. 53-70). The Humana Press Inc.. https://doi.org/10.1007/978-1-4939-3049-4_4
Christiansen, S., Bouzinova, E., Fahrenkrug, J. & Wiborg, O. (2016). Altered expression pattern of clock genes in a rat model of depression. International Journal of Neuropsychopharmacology, 19(11), 1-13. Article pyw061. https://doi.org/10.1093/ijnp/pyw061